Filing Details
- Accession Number:
- 0001181431-14-009224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-25 18:32:04
- Reporting Period:
- 2014-02-21
- Filing Date:
- 2014-02-25
- Accepted Time:
- 2014-02-25 18:32:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1453814 | Medidata Solutions Inc. | MDSO | Services-Prepackaged Software (7372) | 522319066 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1237856 | Cory Douglas | C/O Medidata Solutions, Inc. 350 Hudson Street, 9Th Floor New York NY 10014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-21 | 17,561 | $8.22 | 184,200 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-21 | 17,561 | $64.43 | 166,639 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy) | Disposition | 2014-02-21 | 17,561 | $0.00 | 17,561 | $8.22 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
51,119 | 2021-10-01 | No | 4 | M | Direct |
Footnotes
- Such transaction was executed in multiple trades at prices ranging from $64.45 to $. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options vested as to 25% of the shares on October 1, 2012 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.